Search
News
Roswell Park Team Identifies Factors That Boost Effectiveness of Immunotherapy in Recurrent Ovarian Cancer
… of Immunotherapy in Recurrent Ovarian Cancer Dr. Emese Zsiros leads work exploring interactions of tumor, … treatment options. The study’s senior author, Emese Zsiros, MD, PhD, FACOG , Chair of Gynecologic Oncology and … that does not respond to platinum-based treatments. Dr. Zsiros and her colleagues took the results a step further in …
Page with Layout
Medical Therapy for Cervical Cancer
… Medical Therapy for Cervical Cancer Dr. Emese Zsiros has extensive knowledge in the immuntherapy treatment … of treatments best for you and your cancer. Dr. Emese Zsiros has extensive knowledge in the immuntherapy treatment …
Page with Layout
Clinical Trials for Ovarian Cancer
… with ovarian cancer live longer and live better." Emese Zsiros, MD, PhD Chair, Department of Gynecologic Oncology Dr. Emese Zsiros explains some of the current clinical trials at …
Blog Post
Cancer Innovations: Prioritizing quality of life while treating cancer
… the Cell Stress and Biophysical Therapy Program, and Emese Zsiros, MD, PhD, FACOG , Director of Research in the … more — and better quality — time with their loved ones Dr. Zsiros has spent the past several years researching the use … was 8-15%. The combination has a synergistic effect,” Dr. Zsiros says. “The typical treatments for ovarian cancer …
Blog Post
A decade of advances in ovarian cancer: Julie's story
… screening test that is ready for clinical use,” says Emese Zsiros, MD, PhD, FACOG , and chair of Roswell Park’s … so we do not routinely use that approach today,” Dr. Zsiros explains. A more personalized approach: tumor testing, … selected patients with stage 3 ovarian cancer,” Dr. Zsiros says. “It is an option for selected patients, not a …
Blog Post
Why women with ovarian cancer should consider clinical trials
… better options,” explains gynecologic oncologist Emese Zsiros, MD, PhD, FACOG, of Roswell Park Comprehensive Cancer … for patients who have tried every other option,” says Dr. Zsiros. “Some of the most important clinical trials are … can make informed decisions about their care,” says Dr. Zsiros. Orsolina Sepe enrolled in a clinical trial after …
News
Roswell Park Team Assesses Addition of Complement Inhibitor Drug to Immunotherapy for Ovarian Cancer
… it has been evaluated for the treatment of cancer. Emese Zsiros, MD, PhD, FACOG , serves as principal investigator for … Research Project Grant (R01) awarded to Drs. Zsiros and Segal. “The tumor microenvironment of ovarian … cancer strongly suppresses the immune system,” says Dr. Zsiros, who is Chair of the Department of Gynecologic …
The Shashi Lele, MD, Familial Ovarian Cancer Registry
News
Roswell Park Researchers Uncover Clues to Immunotherapy Response in Patients with Recurrent Ovarian Cancer
… which grew out of a phase 2 clinical trial led by Emese Zsiros, MD, PhD, FACOG , Chair and Director of Research, … can quickly age a patient’s immune system,” explains Dr. Zsiros, a gynecologic oncologist and senior author on the new … due to the weakened state of patients’ immune systems. Dr. Zsiros and team hypothesized that the varied responses …
Blog Post
Cancer Innovations: New initiative reduced prescribed opioids by 45%
… recovery. How would patients fare without opioids? Emese Zsiros, MD, PhD, FACOG, a gynecologic oncologist at Roswell … based on their clinical experience. The results? Dr. Zsiros says the number of opioids prescribed to these … in the fight against the ongoing opioid epidemic.” Dr. Zsiros and her team reported the results from the first six …